Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Pneumoperitoneum after PEG placement is common

The latest Gastrointestinal Endoscopy suggests that pneumoperitoneum after Percutaneous Endoscopic Gastrostomy occurs often, but is not significance in the absence of symptoms.

News image

fiogf49gjkf04

Percutaneous Endoscopic Gastrostomy (PEG) is a widely used method for providing nutritional support.

Although pneumoperitoneum is a known finding after Percutaneous Endoscopic Gastrostomy placement, its true incidence is subject to debate.

Small retrospective studies have found varied rates of free air after Percutaneous Endoscopic Gastrostomy placement.

There were a total of 65 patients.

Dr Ari Wiesen and colleagues from New York assessed the true incidence of pneumoperitoneum and its clinical significance.

No adverse events were associated with PEG placement
Gastrointestinal Endoscopy

The investigators obtained upright and anterior-posterior chest radiographs of 65 patients within 3 hours after Percutaneous Endoscopic Gastrostomy placement.

Type of Percutaneous Endoscopic Gastrostomy tube, gauge of the needle used, number of sticks, and indications were recorded.

The team evaluated the presence of pneumoperitoneum on the initial chest film was considered to be a positive finding.

After a positive result, a repeat chest film was obtained 72 hours later to determine whether there was progression or resolution of the free air.

The investigators monitored patients enrolled clinically for evidence of peritonitis.

Of the 65 patients who underwent Percutaneous Endoscopic Gastrostomy placement, 13 developed a pneumoperitoneum on the initial chest radiograph.

The investigators observed that there was complete resolution of pneumoperitoneum at 72 hours in 10 of the 13 patients.

In 3 patients, the free air persisted but was of no clinical significance.

The team quantified the free air by measuring the height of the air column under the diaphragm and was graded with a scoring system.

The team reported that 11 patients who underwent Percutaneous Endoscopic Gastrostomy died during the hospitalization.

The investigators noted that none of the deaths were related to the Percutaneous Endoscopic Gastrostomy placement or pneumoperitoneum.

The other 54 patients were discharged to a skilled nursing facility.

The team found that none of the patients in the study had clinical evidence of peritonitis.

There were no adverse events, such as, infection or bleeding, associated with the Percutaneous Endoscopic Gastrostomy placement in any of the patients.

Dr Wiesen's team concludes, “Our data suggest that pneumoperitoneum after Percutaneous Endoscopic Gastrostomy placement is common.”

“In the absence of clinical symptoms, it is of no clinical significance and does not warrant any further intervention.”

Gastrointest Endoscopy 2006: 64(6): 886-9
13 December 2006

Go to top of page Email this page Email this page to a colleague

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA
 22 January 2018 
Improving symptoms in GERD
 22 January 2018 
Costs of biologic therapies for IBD in the USA
 22 January 2018 
Western vs Asian guidelines for colon cancer management

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us